These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35867408)

  • 1. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
    Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
    Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
    Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
    Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal and bacterial gut microbiota differ between
    Henderickx JGE; Crobach MJT; Terveer EM; Smits WK; Kuijper EJ; Zwittink RD
    Microbiome Res Rep; 2024; 3(1):8. PubMed ID: 38455084
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
    Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea.
    Villafuerte Gálvez JA; Pollock NR; Alonso CD; Chen X; Xu H; Wang L; White N; Banz A; Miller M; Daugherty K; Gonzalez-Luna AJ; Barrett C; Sprague R; Garey KW; Kelly CP
    Clin Infect Dis; 2023 Feb; 76(3):e1467-e1475. PubMed ID: 35906836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
    Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
    Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of Clostridioides difficile infection in hospitalized patients with new diarrhea: A retrospective cohort study.
    Demir KK; Cheng MP; Lee TC
    PLoS One; 2018; 13(12):e0207128. PubMed ID: 30517148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the gut microbiome of patients with
    Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
    Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
    Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
    Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.
    Sangster W; Hegarty JP; Schieffer KM; Wright JR; Hackman J; Toole DR; Lamendella R; Stewart DB
    Front Microbiol; 2016; 7():789. PubMed ID: 27252696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion.
    Cataldo MA; Granata G; D'Arezzo S; Tonziello G; Vulcano A; De Giuli C; Meledandri M; Di Caro A; Petrosillo N
    Anaerobe; 2021 Aug; 70():102380. PubMed ID: 33971317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
    Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
    Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.